Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ISR - Perspective Therapeutics Inc

Previous close
0.38
0   0%

Share volume: 0
Last Updated: Tue 21 Feb 2023 06:00:00 AM CET
Small Arms, Ordnance, and Ordnance Accessories Manufacturing : 0%

PREVIOUS CLOSE
CHG
CHG%
$0.38
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
370%
Profitability 400%
Dept financing 200%
Liquidity 300%
Performance 400%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-4.00%
1 Month
33.19%
3 Months
3.14%
6 Months
-11.11%
1 Year
2.40%
2 Year
-75.54%
Key data
Stock price
$0.38
P/E Ratio 
0.00
DAY RANGE
$0.38 - $0.38
EPS 
$0.00
52 WEEK RANGE
$0.19 - $0.45
52 WEEK CHANGE
$0.02
MARKET CAP 
54.571 M
YIELD 
N/A
SHARES OUTSTANDING 
142.113 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.88
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$204,898
AVERAGE 30 VOLUME 
$365,681
Company detail
CEO: Lori Woods
Region: US
Website: www.isoray.com
Employees: 64
IPO year: -
Issue type: Common Stock
Market: NYSE American
Industry: Small Arms, Ordnance, and Ordnance Accessories Manufacturing
Sector: Manufacturing

Isoray, Inc., through its subsidiary, Isoray Medical, Inc., is the sole producer of Cesium Blu brachytherapy seeds, which are expanding brachytherapy treatment options throughout the body.

Recent news